Szabó Agnes M, Sipák Zoltán, Miczák András, Faludi Ildikó
Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.
Acta Microbiol Immunol Hung. 2013 Mar;60(1):11-20. doi: 10.1556/AMicr.60.2013.1.2.
Better vaccines and new therapeutic drugs could be a successful breakthrough against intracellular bacteria. M. tuberculosis ABC transporter ATPase (Rv0986) plays a role in mycobacterial virulence by inhibiting phagosome-lysosome fusion. Thus, it could be a potential vaccine candidate. C. pneumoniae another important intracellular bacterium possesses a protein named CpB0255, which is homologous with the mycobacterial Rv0986. The aim of this study was the cloning, over-expression and purification of CpB0255 ABC transporter ATPase protein to study its biological properties. The immunogenicity and protective effect of recombinant chlamydial ATPase protein combined with Alum adjuvant were investigated in mice. The immunization resulted in the reduction of the number of viable C. pneumoniae in the lungs after challenge. Our results confirm that chlamydial ATPase induces protective immunity in mice.
更好的疫苗和新型治疗药物可能是对抗细胞内细菌的一项成功突破。结核分枝杆菌ABC转运体ATP酶(Rv0986)通过抑制吞噬体-溶酶体融合在分枝杆菌毒力中发挥作用。因此,它可能是一种潜在的疫苗候选物。肺炎衣原体是另一种重要的细胞内细菌,它拥有一种名为CpB0255的蛋白质,该蛋白质与分枝杆菌的Rv0986同源。本研究的目的是克隆、过量表达和纯化CpB0255 ABC转运体ATP酶蛋白,以研究其生物学特性。在小鼠中研究了重组衣原体ATP酶蛋白与明矾佐剂联合使用的免疫原性和保护作用。免疫接种导致攻击后肺部存活的肺炎衣原体数量减少。我们的结果证实衣原体ATP酶在小鼠中诱导保护性免疫。